As a Data Scientist at Verana Health, you sit at the critical intersection of advanced data science and clinical research. Your primary mission is to extract actionable insights from complex, real-world healthcare data, ultimately helping to improve patient outcomes and accelerate medical breakthroughs. You are not just building models; you are translating messy, high-dimensional clinical data into strategic evidence that informs life-changing healthcare decisions.
This role requires a unique blend of technical rigor and domain curiosity. You will collaborate closely with cross-functional teams—including clinicians, software engineers, and product managers—to design and implement solutions that scale. Because Verana Health operates in a highly regulated and high-stakes environment, your work must be both innovative and deeply grounded in scientific integrity.
Preparation focus
editorialNo round sequence has been reported for this company, so work the categories below and confirm the format with your recruiter.
What to demonstrate
- Breadth across SQL, experimentation and product reasoning
- Ability to state assumptions before choosing a method
How to prepare
- Drill the practice exercises below and time yourself
- Prepare three quantified stories about decisions you drove
PracHub editorial advice for the preparation topics above.
Ignoring clustering by provider, facility, or site
Patients within a provider panel, and subjects within a trial site, are correlated on both case mix and practice pattern. Standard errors computed as if observations were independent are too narrow by roughly the design effect, 1 + (m - 1) * ICC, where m is the average cluster size. With 50 patients per provider and an intracluster correlation of only 0.02, variance is understated by about a factor of two, which manufactures significant provider differences out of noise. Cluster-robust errors or a random intercept per provider, and cluster-level randomisation when you design the test, are the corrections.
Rates built on member counts rather than exposure
Members join and leave mid-period, so dividing events by distinct members mixes a person covered for 30 days with one covered for 365. New joiners also have artificially low observed utilisation because their claims have not arrived yet and because care takes time to initiate. Denominators must be member-months or member-years, and comparative quality measures usually need a continuous-enrolment requirement with an explicit allowable gap, stated in days.
Sizing estimates built on unnamed, unrevisable assumptions
Write each assumption as a named number you can change, then show the arithmetic so the interviewer can challenge one input instead of the whole answer. Finish by saying which assumption the result is most sensitive to, which matters more than the point estimate.
Naming a model class before naming the deployment constraints
Set out the latency budget, the label delay, the retraining cadence, the interpretability requirement and the number of labelled examples, then pick the model that fits them. A boosted-tree answer to a problem where each decision must be explained to the affected user is a well-executed answer to the wrong question.
Choose a category, try a prompt, then open its approach, worked solution or follow-up when you need it.
Bootstrap a confidence interval for a ratio-of-sums PMPM
You have one row per member for a fully run-out incurred year: member_id, member_months, allowed_amount. Report allowed PMPM, defined as sum(allowed_amount) divided by sum(member_months), with a 95 percent confidence interval from a bootstrap you write yourself. No library resampler. Resample members with replacement, recompute the ratio on each of 2,000 replicates, take a percentile interval, and seed the generator so the result reproduces. In two sentences, state why resampling claim lines instead of members would be wrong.
Approach
- Name the estimator precisely: PMPM is a ratio of sums, not the mean of per-member ratios. The two differ whenever exposure correlates with spend, and it does, because members who churn out mid-year are systematically different from members covered all twelve months.
- Resample the unit of independence, which is the member, and recompute numerator and denominator together on the same draw. Recomputing only the numerator against a fixed denominator understates variance and is a common slip.
- Pull member_months and allowed_amount into numpy arrays once, then draw indices with rng.integers(0, n, size=n) per replicate. Index draws over arrays run one to two orders of magnitude faster than DataFrame.sample, which is the difference between 2,000 replicates and 200.
- Take the 2.5th and 97.5th percentiles of the replicate ratios. Expect an interval that is asymmetric around the point estimate, because healthcare spend is right skewed. That asymmetry is the method working, not a bug to centre away.
- Answer the line-resampling question concretely: the many lines of one high-cost member are not independent draws, so line resampling shrinks the interval toward zero width, and member_months has no line-level analogue, so the denominator becomes undefined.
Follow-up
- Half a percent of members have a transplant or a long NICU stay. Does a percentile interval still have nominal coverage, and what would you do about the tail?
- The question changes to comparing PMPM across provider panels. What becomes the resampling unit and why?
- How would you use the same replicates to test whether this year's PMPM differs from last year's, given the same members appear in both?
Build a claims lag triangle and complete recent months
medical_claim_line has claim_id, claim_version, frequency_code, service_start_date, paid_date, allowed_amount, claim_status. Using 24 fully mature incurred months, build a development triangle of allowed dollars by incurred month and payment lag in whole months, derive cumulative completion factors by chain ladder, then estimate ultimate allowed for the three most recent incurred months at a stated paid-through date. Deduplicate to surviving claim versions before building the triangle. Return incurred_month, paid_to_date, completion_factor, estimated_ultimate.
Approach
- Deduplicate to surviving claim versions and keep paid lines first. A triangle built on all versions develops on adjustment churn rather than on payment timing, and replacements arrive late, so the distortion concentrates in exactly the tail you are trying to estimate.
- Compute lag as a whole-month difference between incurred month and paid month, not as day difference divided by 30. Ragged month lengths otherwise shuffle identical claims between lag buckets depending on which month they fall in.
- Pivot to incurred_month by lag, cumulate along lag, then form age-to-age factors as the ratio of the column L+1 total to the column L total, summed over incurred months mature enough to have both. Volume weighting is the chain ladder; a simple mean of per-month ratios lets one low-volume month dominate the factor.
- Chain the age-to-age factors from each lag to ultimate and invert: completion factor at lag L is the reciprocal of the product of factors from L onward. Apply as estimated_ultimate = paid_to_date / completion_factor.
- State the assumption you have just made, which is that the development pattern is stable. It is not, after a claims-system migration, a network change or a processing backlog, and the most recent month's factor is the least reliable because it rests on the fewest observations while carrying the largest adjustment.
Worked solution 35 min
- Deduplicate to surviving versions, drop voids, keep claim_status 'paid', and derive incurred_month from service_start_date and paid_month from paid_date.
- lag = (paid_month.year - incurred_month.year) x 12 + (paid_month.month - incurred_month.month); drop negative lags and investigate them separately.
- Pivot to a triangle of summed allowed_amount, cumulate along the lag axis, and mask cells past the paid-through date so no cell contains a future payment.
- Compute volume-weighted age-to-age factors per lag over the mature rows, then chain them into cumulative completion factors.
- Apply the factor for each recent month's current maturity to its paid_to_date and return the four columns.
Follow-up
- A processing backlog means the last two months developed slower than history. What does your estimate do, and how would you detect that before reporting?
- Pharmacy, professional and inpatient facility develop on different clocks. How do you split the triangle, and what breaks if the service mix shifts?
- What happens to a PMPM series if someone reports an unadjusted recent month, and in which direction does the error point?
Sessionise transfer chains into episodes, then count readmissions
encounter has encounter_id, patient_id, facility_id, encounter_type, admit_ts, discharge_ts, admission_type, discharge_disposition, is_planned_admission, principal_diagnosis_code. Chain acute-to-acute transfers into episodes of care: an inpatient encounter discharged as transfer_acute, followed by another inpatient encounter for the same patient at a different facility admitting within 24 hours of that discharge, belongs to the same episode. Then compute the 30-day unplanned readmission rate over episodes, excluding index episodes that are planned, that end in expired, hospice or against medical advice, or that are still open. Return encounter_id to episode_id, plus the rate.
Approach
- Restrict to inpatient encounters for the chaining step and sort by patient_id, admit_ts. Observation and emergency encounters are not acute inpatient stays and pooling them changes both the chain and the denominator.
- Build a boolean continues flag: the previous row is the same patient, its discharge_disposition is transfer_acute, its facility_id differs from this row's, and admit_ts minus previous discharge_ts is between 0 and 24 hours. Episode id = cumsum of the negation of that flag. This is the vectorised form of a sessionisation loop and is why the pattern generalises to any event stream.
- Collapse to episode grain taking first admit_ts, last discharge_ts, last discharge_disposition, and any() of is_planned_admission. The episode inherits its exit state, not its entry state, which is why a transfer chain ending at home is one home discharge rather than two transfers.
- Apply index exclusions at episode grain. Dropping episodes that end in death is not optional: a dead patient cannot be readmitted, so leaving them in inflates the denominator and depresses the rate for exactly the panels caring for the sickest members.
- For each surviving index episode, find the next unplanned acute inpatient episode for that patient admitting within 30 days of the index discharge_ts. Count events at episode grain, since one patient can contribute several index episodes. Report the raw rate and say plainly that it is not comparable across panels without risk adjustment, which is what the observed-over-expected form exists for.
Follow-up
- discharge_ts is null on an open stay in the middle of a chain. What does your flag do, and what should it do?
- A patient is transferred out and then back to the originating facility within 24 hours. Should that chain, and does your facility_id condition handle it?
- Is a readmission itself eligible to serve as a later index episode? Say what you chose and what the choice does to the rate.
Find inpatient encounters with no resulted lab during the stay
encounter holds encounter_id, patient_id, encounter_type, admit_ts, discharge_ts and facility_id. lab_result holds result_id, order_id, patient_id, encounter_id (NULL for outpatient standing orders), loinc_code, specimen_collected_ts, resulted_ts and result_status. Return every inpatient encounter discharged in 2025 with no final or corrected lab_result linked to it. A colleague wrote WHERE encounter_id NOT IN (SELECT encounter_id FROM lab_result) and got zero rows back. Say why, write the correct query, then say what changes when labs must instead be matched on patient_id with the specimen collected between admit_ts and discharge_ts.
Approach
- Name the mechanism rather than the symptom. x NOT IN (subquery) expands to x <> y1 AND x <> y2 AND ..., and a single NULL y makes that chain UNKNOWN, never TRUE. Since lab_result.encounter_id is nullable by design for standing orders, this query can only ever return zero rows.
- Rewrite as NOT EXISTS, or LEFT JOIN with an IS NULL filter. Both treat a NULL key as no match rather than as unknown. Adding IS NOT NULL inside the NOT IN subquery also works, but NOT EXISTS is the habit that survives someone making another column nullable later.
- Put the result_status predicate inside the correlated subquery or the ON clause, not in an outer WHERE. Outside, it turns the anti-join back into an inner join and an encounter whose only labs were cancelled disappears instead of qualifying.
- For the timestamp variant, match on patient_id with specimen_collected_ts inside the stay rather than resulted_ts. A specimen drawn an hour before discharge can result the next day, and anchoring on resulted_ts would wrongly call that stay lab-free.
- Restrict to encounter_type 'inpatient' and discharge_ts in 2025, and report open encounters with a NULL discharge_ts as a separate count instead of letting the filter swallow them.
Follow-up
- Write the LEFT JOIN form and say exactly where the result_status predicate must sit for the two forms to agree.
- How would you separate encounters whose only labs were cancelled from encounters with no lab rows at all?
- Some encounters carry member_id NULL because the person index did not match. What does that do to a payer-side version of this measure?
Report site activation to first randomization without hiding non-enrollers
study_site holds one row per (study_id, site_id): site_activation_date, which is NULL for a site selected but never activated, and site_status. study_subject_visit holds subject_visit_id, study_id, site_id, subject_id, randomization_ts (NULL for screen failures), visit_name, visit_number, actual_visit_date and visit_status, with one row per subject per protocol visit, so randomization_ts repeats across every visit of a randomized subject and a site that has screened nobody has no rows there at all. For one study_id and a stated data cut date, return per activated site the activation date, the first randomization_ts and the days between them, with activated sites that have randomized nobody still present. Add a study-level summary giving median days to first randomization and the share of activated sites with no randomization by day 90.
Approach
- Take the site universe from study_site, never from study_subject_visit. The visit table can only contain sites that have screened at least one subject, so a universe built from DISTINCT site_id there omits exactly the sites this metric exists to expose. Filter study_site to the study and to site_activation_date IS NOT NULL, then LEFT JOIN the per-site first randomization.
- Collapse the grain before aggregating anything on the visit side. The table repeats randomization_ts across every visit of a randomized subject, so any count taken at row grain is inflated by visits per subject. MIN(randomization_ts) per site is safe, COUNT is not.
- State the date boundary rule. randomization_ts is a timestamp and site_activation_date is a date, so a randomization at 23:40 local time can land on either side of a day boundary depending on the zone the timestamp is stored in. Cast once, deliberately, and say which zone.
- Use PERCENTILE_CONT(0.5) WITHIN GROUP (ORDER BY days) for the median and be explicit that it ignores NULLs, so it is a median over enrolling sites only. That is exactly why the non-enroller share is reported beside it rather than instead of it.
- Censor the day-90 denominator against the data cut. A site activated 40 days before the cut has not had 90 days to randomize, so it cannot be scored on that bar and belongs outside that denominator.
Worked solution 25 min
- CTE sites: site_id and site_activation_date from study_site for the study where site_activation_date IS NOT NULL. The (study_id, site_id) key already gives one activation date per site, so assert that key rather than de-duplicating defensively.
- CTE first_rand: site_id and MIN(randomization_ts) over study_subject_visit rows for the study where randomization_ts IS NOT NULL, grouped by site_id.
- LEFT JOIN sites to first_rand and compute days_to_first_randomization with an explicit cast of the timestamp to a date.
- Summary: PERCENTILE_CONT(0.5) over non-null days, plus the count and share of sites with no randomization by day 90, restricted to sites activated at least 90 days before the data cut.
- Compare the site-level row count with COUNT(DISTINCT site_id) in study_subject_visit for the study; the difference is the activated sites that have screened nobody, which is the population the metric is for.
Follow-up
- The same site_id appears under two studies. What breaks, and what is the correct grain for this metric?
- Would you present this as a median, as a Kaplan-Meier curve of time to first randomization, or both, and what does the curve show that the median cannot?
- A site randomized one subject who withdrew at visit 2. Does that site count as enrolling here, and how does that differ from a randomized-and-retained measure?
Can you walk us through a recent research project and the specific tec…
Can you walk us through a recent research project and the specific technical challenges you overcame?
Approach
- State your assumptions explicitly before working the problem.
- Work from the decision backwards to the evidence you would need.
- Say what you would check first and why it is the highest-information step.
Follow-up
- How would you know your answer was wrong?
- What assumption would you test first?
How do you ensure your analysis is reproducible and robust?
How do you ensure your analysis is reproducible and robust?
Approach
- Clarify what is being asked and what a complete answer would contain.
- State your assumptions explicitly before working the problem.
- Say what you would check first and why it is the highest-information step.
Follow-up
- How would you know your answer was wrong?
- What assumption would you test first?
What techniques do you use to validate the reliability of your models?
What techniques do you use to validate the reliability of your models?
Approach
- State your assumptions explicitly before working the problem.
- Clarify what is being asked and what a complete answer would contain.
- Say what you would check first and why it is the highest-information step.
Follow-up
- What assumption would you test first?
- How would you know your answer was wrong?
Plan interim looks and multiplicity control for a year-long trial
A 12-month cluster-randomised care-management trial has one primary endpoint (ambulatory care sensitive admissions per 1,000 member-years), three secondary endpoints, and five pre-specified subgroups. The steering group wants a read every month. At month 2 the primary is nominally significant at p = 0.03 with an effect roughly three times the powered assumption. Write the monitoring and analysis plan that should have been in place, and say precisely what you tell the steering group about month 2.
Approach
- Quantify the peeking cost rather than asserting it. Testing accumulating data repeatedly at a fixed nominal 0.05 raises the overall type I error to roughly 0.14 at five equally spaced looks and roughly 0.19 at ten; a monthly read for a year is worse than either.
- Replace fixed-threshold looks with a Lan-DeMets alpha-spending plan on a pre-specified number of looks. An O'Brien-Fleming spending function is right here because it spends almost nothing early (a first look needs a nominal p on the order of 1e-5) and preserves close to 0.05 for the final analysis; Pocock's constant boundary (about 0.0158 nominal at each of five looks) buys early stopping power at the cost of a stricter final look. Monitor the safety guardrail on a separate, non-binding harm boundary, because stopping for harm is a different decision from stopping for efficacy.
- Control the endpoint family with a gatekeeping structure: test the primary at full alpha, and only on success test the three secondaries in a pre-specified fixed sequence or with Holm. Declare the five subgroups exploratory, test them as treatment-by-subgroup interactions rather than as within-subgroup significance, and report them with FDR control and that label attached.
- Separate the three distinct reasons the month-2 effect is inflated. Alpha inflation from the unplanned look is one. Early-exposure inflation is another, since the first clusters to go live are the enthusiastic ones and their staff are running a new process attentively, which decays as it becomes routine. Claims incompleteness is the third and is specific to this outcome: inpatient facility claims run out over months, so month 2 admission counts are undercounted, and the undercount does not have to be equal across arms.
- Tell the steering group that month 2 is not a result: p = 0.03 is nowhere near any defensible first-look boundary, the recent incurred months are incomplete at the stated paid-through date, and estimates taken at a crossing are conditionally biased upward, so even a real stop would require a bias-adjusted effect estimate rather than the raw one.
Worked solution 40 min
- State the fixed number of interim analyses and the information fractions at which they occur, then pick the spending function and derive nominal boundaries so the total spend equals 0.05.
- Write the gatekeeping rule for the three secondaries and the exploratory label plus FDR rule for the five subgroups.
- Specify that the primary is computed only at a stated paid-through date, with the three most recent incurred months either held back or completion-factored.
- Add an exposure-time analysis: index every cluster on its own go-live date and report the effect by cluster-months since activation, so habituation and staggered rollout are visible rather than pooled away.
- Write the month-2 statement: the boundary was not crossed, the data are incomplete, and no effect estimate will be circulated.
Follow-up
- The steering group insists on monthly visibility. What can you show them every month that does not spend alpha?
- How would you tell a genuine effect apart from an exposure-time artefact when clusters went live on a staggered schedule?
- If the trial does cross an efficacy boundary at month 8, what effect estimate do you publish and why is it not the raw one?
First-pass denial rate doubled in one received week
First-pass denial rate jumped from 6.1 to 11.8 percent in a single received_date week and stayed at the new level. Nothing in the adjudication rules changed that week. You have medical_claim_line: claim_id, claim_version, frequency_code, claim_status, denial_reason_code, member_id, received_date, adjudicated_at, billing_provider_npi. The metric counts lines whose first adjudication returns 'denied', over lines received in the window at claim_version = 1. Find the cause, say whether denial behaviour actually changed, and deliver the corrected series plus the query change that fixes it.
Approach
- Cut the excess by denial_reason_code before anything else. A behaviour change spreads across codes; an upstream failure concentrates in one. If a single eligibility-related code carries nearly all of the 5.7 point excess, the claims are fine and the eligibility data was not.
- Join the denied lines to member_enrollment and compare the span's created_at to the claim's received_date. Lines denied for members whose coverage span loaded after the claim arrived are a load-ordering failure, not a coding failure.
- Check resolution downstream: take those claim_ids and look for a later version with frequency_code 7 that adjudicates to 'paid'. A high resubmit-and-pay share confirms the denial was transient and recoverable.
- Verify the denominator is not the mover. Count lines at claim_version = 1 by received_date and check the weekday mix, because submission batching makes received_date strongly day-of-week patterned and a short or holiday week shifts the denominator without changing behaviour.
- Confirm runout: the metric should be held until 60 days of adjudication have passed, so check that the comparison weeks are equally mature rather than comparing a settled week to a fresh one.
- Restate the series with the affected reason code broken out as its own line, and change the query to carry denial_reason_code into the reported breakdown rather than only the headline rate.
Follow-up
- The affected lines all get paid on resubmission. Is the first-pass denial rate then wrong, or right and uninteresting?
- How would you monitor for this class of failure without waiting for someone to notice a chart?
- What changes if the excess is spread evenly across denial_reason_code instead of concentrated?
Four days spend equal time on query work, statistics, modelling and product judgement at deliberately shallow depth, which produces a scored map of where you actually stand. The last three days spend everything on the two areas the role weights most, and close by re-running day one to measure movement.
Prepare, practise & reflect
One practical outcome each day. Spend longer where you need it.
0 / 7 done01Breadth pass: query fluency
- Solve six prompts spanning aggregation, joins, window functions and date arithmetic in 60 minutes total, stopping at 10 minutes each whether or not it works, and mark every prompt as solved, solved slowly, or stuck.
- For each unsolved prompt write the single blocking sentence (I lost the grain, I did not know the frame clause, I could not express the date boundary) instead of reading the solution.
- Translate one pandas transformation you know well into SQL and one SQL query into pandas, checking that both return the same row count and the same totals.
Deliverable: A scored six-row table, one line per prompt, saved for the day-seven re-run.
Practice prompt ↗Practice prompt ↗Worked solution ↗02Breadth pass: statistics and inference
- Answer ten short questions in writing with nothing open: what a p-value is conditional on, what a 95 percent interval covers across repeated samples, when a paired test is the right one, what the bootstrap estimates, why multiple comparisons inflate false positives, how controlling the family-wise error rate differs from controlling the false discovery rate, what power depends on, what a missed real effect costs a product, the three situations where the central limit theorem does not rescue you (small n, very heavy tails, dependent observations), and what a standard error is the standard deviation of.
- Grade yourself against a reference and count only the answers that were exactly right, not the ones that were nearly right.
- Rewrite the two weakest answers the following morning from memory in full sentences.
Deliverable: Ten graded answers with an honest count of exact hits.
Practice prompt ↗Practice prompt ↗03Breadth pass: modelling
- Take one tabular dataset end to end in 90 minutes: a leakage-safe split, a baseline that is not a model (majority class or historical mean), one regularized linear model, one gradient-boosted tree, and a single evaluation metric chosen before you look at any result.
- Write why that metric fits the cost structure: precision at a fixed recall for alerting, calibration for anything feeding a price or a threshold, ranking metrics for retrieval, and note that area under the ROC curve is insensitive to class balance in a way that can flatter a rare-positive problem.
- Name the leak you were most likely to introduce (an encoding fit on all rows before splitting, or a feature computed after the label's timestamp) and write the check that would have caught it.
Deliverable: A notebook whose first cell states the metric and the baseline, plus two lines on what beat what and by how much.
Practice prompt ↗Practice prompt ↗04Breadth pass: product judgement
- Answer three case prompts aloud at 15 minutes each, timing how long passes before you state a success metric.
- For one case write the first segmentation you would run and the row counts you expect per segment, so that a tiny segment cannot quietly drive the conclusion.
- Take a metric definition you did not write, from a public dashboard, a textbook, or documentation you already have open, and list every place two analysts implementing it would diverge: which rows the denominator admits, whether the unit is an account or a person, what the time window is anchored to, and what happens to data that arrives late. Then write the one question that would close the largest of those gaps.
Deliverable: Three recorded case answers plus an ambiguity list for a metric someone else defined, ending in the single question you would ask about it.
Practice prompt ↗Practice prompt ↗Worked solution ↗05Depth, first area
- Rank the four areas by how many bullet points in the role description each one covers, pick the top one, and spend the entire day inside it.
- Work the six hardest problems you can find in that area and for each write the generalizable move you should have reached for first, rather than the answer.
- Re-solve the two you failed the same evening with notes closed.
Deliverable: Six generalizable moves written as instructions to yourself, not as solutions.
Practice prompt ↗Practice prompt ↗06Depth, second area, and the seam between them
- Repeat the depth protocol on the second-ranked area with the same six-problem structure.
- Construct one problem that requires both areas at once, for example a metric redefinition whose effect you must validate with a test whose readout you then have to query.
- Solve your own combined problem end to end and note where the handoff between the two areas cost you time.
Deliverable: One combined problem, solved end to end, with the handoff failure written down.
Practice prompt ↗Practice prompt ↗07Integration and re-measurement
- Re-run the six prompts from day one under the same clock and compare both correctness and time.
- Run a 60-minute mixed mock that moves between areas without warning, since switching cost is what breadth passes do not train.
- Write the two areas you would still fail on, and the sentence you will use in the interview when you hit one of them.
Deliverable: A before-and-after score table plus a written plan for the two remaining gaps.
Practice prompt ↗Worked solution ↗Expand any day for tasks and deliverables. Your progress is saved on this device.
An answer without a quantity is hard to interrogate, so interviewers keep probing until they find one. Come with the baseline, the change, the window it was measured over, and how confident you were. If the effect never got measured, say so and say what you would have measured. Fabricated precision is worse than an honest gap.
How do you handle missing or noisy data in a clinical dataset?
How do you handle missing or noisy data in a clinical dataset?
Approach
- Name the disagreement or constraint, and how you resolved it with evidence.
- Quantify the outcome, including what you would not claim credit for.
- Close with what you would do differently, concretely.
Follow-up
- What would you do differently if you ran that project again?
- How did you know the outcome was caused by your change?
Describe a time you had to pivot your technical approach mid-project.
Describe a time you had to pivot your technical approach mid-project.
Approach
- Quantify the outcome, including what you would not claim credit for.
- Close with what you would do differently, concretely.
- State the situation in two sentences and spend the rest on your reasoning.
Follow-up
- What did you decide not to do, and why?
- What would you do differently if you ran that project again?
Disagree with a product manager about an adherence nudge
A product manager proposes shipping a refill-reminder feature to the whole member base, citing an internal analysis: members with 12-month proportion of days covered at or above 0.80 had 31 percent fewer admissions than members below it. The roadmap date is three weeks out and engineering is scoped. You believe the comparison builds survival and continuous coverage into the exposure definition, and is separately confounded by the kind of member who refills on time. Deliverable: what you say in the room, what you send afterwards, and the smallest study you would accept as sufficient to ship.
Approach
- The probe is whether you can be specific and non-territorial at once. A disagreement that arrives as 'the analysis is flawed' costs you the room; one that names a mechanism and offers a cheaper path keeps it.
- Name the two defects separately, because they have different fixes. Classifying a member as adherent over 12 months requires them to stay alive and stay covered for those 12 months, and that guaranteed event-free interval is assigned to the adherent group. Separately, members who refill on schedule differ from those who do not in ways claims never record.
- Show rather than assert. Rerun the same comparison as a landmark analysis: classify adherence over days 1 to 90, start follow-up at day 91 for everyone still enrolled and event-free, and report how much of the 31 percent survives.
- Separate the association claim from the intervention claim out loud. Nothing in the analysis speaks to whether a reminder changes refill behaviour, which is the actual product question and is separately testable.
- Offer the shippable path: a randomised holdout on a subset with proportion of days covered as the primary endpoint, powered on the plausible effect of a reminder rather than on the 31 percent, with a stated read date.
Follow-up
- The landmark rerun still shows a 20 percent difference. Do you ship?
- The product manager says a holdout delays launch. How do you cost that argument?
- What primary endpoint do you choose, and why not admissions?
- 01
How do you handle missing or noisy data in a clinical dataset?
- 02
Describe a time you had to pivot your technical approach mid-project.
- 03
A product manager proposes shipping a refill-reminder feature to the whole member base, citing an internal analysis: members with 12-month proportion of days covered at or above 0.80 had 31 percent fewer admissions than members below it. The roadmap date is three weeks out and engineering is scoped. You believe the comparison builds survival and continuous coverage into the exposure definition, and is separately confounded by the kind of member who refills on time. Deliverable: what you say in the room, what you send afterwards, and the smallest study you would accept as sufficient to ship.
Is this an official Verana Health interview guide?
No. It is PracHub's own research and practice material for the Data Scientist role at Verana Health. Rounds and questions reflect what candidates have reported, not a process Verana Health has published, and they change over time. Confirm the current format and scope with your recruiter.
PracHub interview research ↗How long does the typical interview process take?
While experiences vary, expect a timeline of several weeks. Maintain consistent communication with your recruiter to keep the process moving.
PracHub interview research ↗What is the most important trait for a candidate to demonstrate?
The ability to explain the "why" behind your technical decisions is paramount. Verana Health values candidates who can balance technical complexity with clear, mission-driven communication.
PracHub interview research ↗Are there any specific cultural aspects I should be aware of?
Verana Health is a team-oriented environment. Be prepared to show how you contribute to a positive, collaborative culture, especially when navigating project ambiguity.
PracHub interview research ↗How should I handle a question I don't know the answer to?
Be honest. Walk the interviewer through how you would go about finding the answer or the framework you would use to approach the problem.
PracHub interview research ↗Sources & methodology 3 sources ↗
No official company page is cited. Rounds and questions come from candidate reports and PracHub editorial material; each source shows the date it was read.
- 01PracHub interview research ↗
PracHub editorial research into this company and role, maintained with this guide. Candidate-reported, not an employer publication.
PracHub page · Accessed 2026-09-22 - 02PracHub Data Scientist practice ↗
Cross-company practice questions for this role.
PracHub page · Accessed 2026-09-22 - 03PracHub interview preparation framework ↗
The framework the preparation plan follows.
PracHub page · Accessed 2026-09-22
Explore related engineering environments and compare the preparation focus.
Veracyte Data Scientist Interview Questions & Guide 2026
Causal-inference exercises for Veracyte data scientist prep: difference-in-differences, matching, instrumental variables, and knowing when observational data simply cannot answer the question asked.
Zoetis Data Scientist Interview Questions & Guide 2026
Metric-diagnosis practice for Zoetis data scientist candidates: a number moves week over week and you work out why, splitting by segment, ruling out a logging or release change, and separating a mix shift from a real change in user behaviou
Vizient Data Scientist Interview Questions & Guide 2026
Communication practice for Vizient data scientist candidates: turn an analysis into a recommendation, name the uncertainty honestly, and answer the follow-up a skeptical stakeholder will raise.
Vibrant Emotional Health Data Scientist Interview Questions & Guide 2026
Case practice for the Vibrant Emotional Health data scientist interview, where the prompt is deliberately underspecified and your first move is scoping it into something measurable.